DeMariaTFPriorRBBriggsBRLimDJBirckHG. Endotoxin in middle ear effusions from patients with chronic otitis media with effusion. In: LimDJ, ed. Recent advances in otitis media with effusion. Philadelphia: BC Decker, 1984:123–5.
5.
LeinonenMK. Detection of pneumococcal capsular polysaccharide antigens by latex agglutination, counterimmunoelectrophoresis, and radioimmunoassay in middle ear exudates in acute otitis media. J Clin Microbiol1980;11:135–40.
6.
TuomanenETomaszAHengstlerBZakO.The relative role of bacterial cell wall and capsule in the induction of inflammation in pneumococcal meningitis. J Infect Dis1985;151:535–40.
7.
TuomanenERichRZakO.Induction of pulmonary inflammation by components of the pneumococcal cell wall surface. Am Rev Respir Dis1987;135:869–74.
8.
JuhnSKPaparellaMMKimCSGoycooleaMVGiebinkS.Pathogenesis of otitis media. Ann Otol Rhinol Laryngol1977;86:481–92.
9.
TuomanenELiuHHengstlerBZakOTomaszA.The induction of meningeal inflammation by components of the pneumococcal cell wall. J Infect Dis1985;151:859–68.
10.
Ripley-PetzoldtMLGiebinkGSJuhnSKAeppliDTomaszATuomanenE.The contribution of pneumococcal cell wall to the pathogenesis of experimental otitis media. J Infect Dis1988;157:245–55.
11.
GiebinkGSPayneEEMillsELJuhnSKQuiePG. Experimental otitis media due to Streptococcus pneumoniae: Immunopathogenic response in the chinchilla. J Infect Dis1976; 134:595–604.
12.
TuomanenEHengstlerBZakOTomaszA.The role of complement in inflammation during experimental pneumococcal meningitis. Microb Pathogen1986;1:15–32.
13.
TuomanenEHengstlerBRichRBragMAZakOTomaszA.Nonsteroidal anti-inflammatory agents in the therapy for experimental pneumococcal meningitis. J Infect Dis1987;155:985–90.
